These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 65226)

  • 21. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of intracoronary lidocaine on ventricular arrhythmia in the infarcted canine heart.
    Tordjman T; Raeder E; Lampert S; Lown B
    Pharmacotherapy; 1988; 8(5):295-8. PubMed ID: 3252195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time course of changes in ventricular excitability and conduction during myocardial ischemia and reperfusion in the dog: effect of lidocaine.
    Avitall B; Naimi S; Levine HJ; Mieszala J
    J Electrocardiol; 1979 Jul; 12(3):271-7. PubMed ID: 89180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tocainide.
    Danilo P
    Am Heart J; 1979 Feb; 97(2):259-62. PubMed ID: 760455
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure of antiarrhythmic drugs to affect epicardial delay during acute experimental coronary artery occlusion and reperfusion: correlation with lack of antiarrhythmic efficacy.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    J Pharmacol Exp Ther; 1981 Aug; 218(2):475-80. PubMed ID: 7252847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical pharmacology of lidocaine as an antiarrhythymic drug.
    Collinsworth KA; Kalman SM; Harrison DC
    Circulation; 1974 Dec; 50(6):1217-30. PubMed ID: 4609637
    [No Abstract]   [Full Text] [Related]  

  • 28. N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent: effects on cardiac conduction.
    Hidaka T; Hamasaki S; Aisaka K; Ishihara T; Morita M; Toyama J; Yamada K
    Arzneimittelforschung; 1985; 35(9):1381-6. PubMed ID: 4084339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.
    Naito M; Michelson EL; Kmetzo JJ; Kaplinsky E; Dreifus LS
    Circulation; 1981 Jan; 63(1):70-9. PubMed ID: 7438409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of methyllidocaine and lidocaine on arrhythmias produced by coronary occlusion in the dog.
    Gillis RA; Levine FH; Thibodeaux H; Raines A; Standaert FG
    Circulation; 1973 Apr; 47(4):697-703. PubMed ID: 4696791
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
    Patterson E; Gibson JK; Lucchesi BR
    Pharmacology; 1988; 36(2):73-83. PubMed ID: 3353442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT
    J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
    [No Abstract]   [Full Text] [Related]  

  • 33. The acute antiarrhythmic effects of droxicainide and lidocaine in unanesthetized dogs.
    Aberg G; Ronfeld R; Smith E
    J Cardiovasc Pharmacol; 1984; 6(2):355-60. PubMed ID: 6200728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lidocaine on conduction within normal and acutely ischemic ventricular myocardium of dogs.
    Okumura K; Horio Y; Tokuomi H
    Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):269-82. PubMed ID: 7103614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism for the antiarrhythmic effect of helium in anesthetized dogs.
    Raymond L; Weiskopf RB; Halsey MJ; Goldfien A; Eger EI; Severinghaus JW
    Science; 1972 Jun; 176(4040):1250-2. PubMed ID: 5033644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A preclinical study of EO-122, a new lidocaine-like antiarrhythmic drug.
    Oppenheimer E; Kaplinsky E; Kariv N; Bruckstein R; Cohen S
    Angiology; 1980 Jun; 31(6):410-26. PubMed ID: 7416554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 38. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia.
    Hashimoto K; Satoh H; Shibuya T; Imai S
    J Pharmacol Exp Ther; 1982 Dec; 223(3):801-10. PubMed ID: 7143241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart.
    Fazekas T; Scherlag BJ; Mabo P; Berlin KD; Garrison GL; Chen CL; Sangiah S; Patterson E; Lazzara R
    Acta Physiol Hung; 1993; 81(3):289-99. PubMed ID: 8197884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes.
    Yamamoto K; Bando S
    Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.